PRESS RELEASES
<< Back
Xcel Brands, Inc. Announces Third Quarter 2023 Results
- Entered into licensing agreements for the Company’s Longaberger eCommerce business and made in the US baskets in
November 2023 , thereby completing the previously disclosed restructuring plan to exit all operating businesses. - Licensing revenues of
$2.6 million for the quarter, an increase of$0.2 million as compared to the quarter endedJune 30, 2023 . - GAAP net loss of
$5.1 million for the quarter, compared with GAAP net loss of$4.0 million in the prior year quarter. - Adjusted EBITDA of
($1.4) million for the quarter, compared with Adjusted EBITDA of($2.9) million for the prior year quarter.
Mr. D’Loren continued, “Our third quarter adjusted EBITDA was lower than expected as a result of soft sales in our Interactive TV business primarily driven by talent scheduling conflicts as QVC transitions post-COVID from remote shows to 100% in-studio shows. However, we expect overall licensing revenue to grow sequentially in the fourth quarter and beyond as recently signed agreements with G-III for our
“We also remain on track to launch our livestream and social commerce platform during the 2023 fourth quarter. This powerful platform is an exciting opportunity with strong growth potential for the Company, and we are looking forward to being able to share more details about the launch in the coming weeks. While the overall retail environment remains extremely fluid, I am pleased with the progress we are making and the opportunities we are pursuing to drive long-term shareholder value,” concluded Mr. D’Loren.
Third Quarter 2023 Financial Results
Net revenue for the third quarter of 2023 was
Net loss attributable to
After adjusting for certain cash and non-cash items, results on a non-GAAP basis were a net loss of approximately
Adjusted EBITDA improved significantly on a year-over-year basis to negative
Nine Month 2023 Financial Results
Net revenue for the current nine-month period was
Net loss attributable to
After adjusting for certain cash and non-cash items, results on a non-GAAP basis were a net loss of approximately
Adjusted EBITDA was negative
Balance Sheet
The Company's balance sheet at
The Company did not have any short-term or long-term debt as of
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details at
800-715-9871 or 646-307-1963 and use the conference ID 8167522. A replay of the webcast will be available on Xcel’s website.
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
216-464-6400
andrew@smberger.com
Unaudited Condensed Consolidated Statements of Operations | ||||||||||||||||
(in thousands, except share and per share data) | ||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Revenues | ||||||||||||||||
Net licensing revenue | $ | 2,381 | $ | 2,166 | $ | 7,031 | $ | 13,302 | ||||||||
Net sales | 256 | 2,335 | 8,437 | 8,413 | ||||||||||||
Net revenue | 2,637 | 4,501 | 15,468 | 21,715 | ||||||||||||
Cost of goods sold | 225 | 1,465 | 6,718 | 5,715 | ||||||||||||
Gross profit | 2,412 | 3,036 | 8,750 | 16,000 | ||||||||||||
Operating costs and expenses | ||||||||||||||||
Salaries, benefits and employment taxes | 2,141 | 3,301 | 7,847 | 13,390 | ||||||||||||
Other selling, general and administrative expenses | 3,482 | 3,618 | 9,918 | 11,330 | ||||||||||||
Total operating costs and expenses | 5,623 | 6,919 | 17,765 | 24,720 | ||||||||||||
Operating loss before other expenses, including non-cash expenses | (3,211 | ) | (3,883 | ) | (9,015 | ) | (8,720 | ) | ||||||||
Other expense, including non-cash expenses | ||||||||||||||||
Depreciation and amortization | 1,677 | 1,815 | 5,260 | 5,447 | ||||||||||||
Gain on sale of assets | - | - | - | (20,608 | ) | |||||||||||
Loss from equity method investment | 515 | 277 | 1,545 | 277 | ||||||||||||
Gain on sale of limited partner ownership | - | - | (351 | ) | - | |||||||||||
Gain on Lease Liability | - | - | (445 | ) | - | |||||||||||
Operating (loss) income | (5,403 | ) | (5,975 | ) | (15,024 | ) | 6,164 | |||||||||
Interest and finance expense | ||||||||||||||||
Interest expense - term loan debt | - | - | - | 1,187 | ||||||||||||
Other interest and finance charges (income), net | - | (6 | ) | 18 | (6.00 | ) | ||||||||||
Loss on early extinguishment of debt | - | - | - | 2,324 | ||||||||||||
Total interest and finance expense | - | (6 | ) | 18 | 3,505 | |||||||||||
(Loss) income before income taxes | (5,403 | ) | (5,969 | ) | (15,042 | ) | 2,659 | |||||||||
Income tax (benefit) provision | - | (1,539 | ) | - | 1,639 | |||||||||||
Net (loss) income | (5,403 | ) | (4,430 | ) | (15,042 | ) | 1,020 | |||||||||
Less: Net loss attributable to noncontrolling interest | (259 | ) | (388 | ) | (787 | ) | (941 | ) | ||||||||
Net (loss) income attributable to |
$ | (5,144 | ) | $ | (4,042 | ) | $ | (14,255 | ) | $ | 1,961 | |||||
(Loss) earnings per share attributed to |
||||||||||||||||
Basic net (loss) income per share | $ | (0.26 | ) | $ | (0.21 | ) | $ | (0.72 | ) | $ | 0.10 | |||||
Diluted net (loss) income per share | $ | (0.26 | ) | $ | (0.21 | ) | $ | (0.72 | ) | $ | 0.10 | |||||
Basic weighted average common shares outstanding | 19,749,317 | 19,624,860 | 19,683,525 | 19,624,604 | ||||||||||||
Diluted weighted average common shares outstanding | 19,749,317 | 19,624,860 | 19,683,525 | 19,752,339 | ||||||||||||
Unaudited Condensed Consolidated Balance Sheets | ||||||||||
(in thousands, except share and per share data) | ||||||||||
(Unaudited) | ||||||||||
Assets | ||||||||||
Current Assets: | ||||||||||
Cash and cash equivalents | $ | 2,189 | $ | 4,608 | ||||||
Accounts receivable, net | 4,749 | 5,110 | ||||||||
Inventory | 997 | 2,845 | ||||||||
Prepaid expenses and other current assets | 447 | 1,457 | ||||||||
Total current assets | 8,382 | 14,020 | ||||||||
Non-Current Assets: | ||||||||||
Property and equipment, net | 779 | 1,418 | ||||||||
Operating lease right-of-use assets | 4,702 | 5,420 | ||||||||
Trademarks and other intangibles, net | 43,055 | 47,665 | ||||||||
Equity method investment | 17,650 | 19,195 | ||||||||
Deferred tax assets, net | 1,107 | 1,107 | ||||||||
Other assets | 75 | 110 | ||||||||
Total non-current assets | 67,368 | 74,915 | ||||||||
Total Assets | $ | 75,750 | $ | 88,935 | ||||||
Liabilities and Equity | ||||||||||
Current Liabilities: | ||||||||||
Accounts payable, accrued expenses and other current liabilities | $ | 3,621 | $ | 4,438 | ||||||
Deferred revenue | 889 | 88 | ||||||||
Accrued payroll | 80 | 416 | ||||||||
Current portion of operating lease obligations | 1,219 | 1,376 | ||||||||
Current portion of contingent obligations | 847 | 243 | ||||||||
Total current liabilities | 6,656 | 6,561 | ||||||||
Long-Term Liabilities: | ||||||||||
Long-term portion of operating lease obligations | 4,362 | 5,839 | ||||||||
Long-term Deferred revenue | 3,875 | - | ||||||||
Contingent obligations | 5,548 | 6,396 | ||||||||
Total long-term liabilities | 13,785 | 12,235 | ||||||||
Total Liabilities | 20,441 | 18,796 | ||||||||
Commitments and Contingencies | ||||||||||
Equity: | ||||||||||
Preferred stock, |
- | - | ||||||||
Common stock, |
20 | 20 | ||||||||
Paid-in capital | 103,804 | 103,592 | ||||||||
Accumulated deficit | (47,052 | ) | (32,797 | ) | ||||||
56,772 | 70,815 | |||||||||
Noncontrolling interest | (1,463 | ) | (676 | ) | ||||||
Total Equity | 55,309 | 70,139 | ||||||||
Total Liabilities and Equity | $ | 75,750 | $ | 88,935 | ||||||
Unaudited Condensed Consolidated Statements of Cash Flows | |||||||||
(in thousands) | |||||||||
For the Nine Months Ended | |||||||||
2023 | 2022 | ||||||||
Cash flows from operating activities | |||||||||
Net (loss) income | $ | (15,042 | ) | $ | 1,020 | ||||
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||||||||
Depreciation and amortization expense | 5,260 | 5,447 | |||||||
Asset impairment charges | 100 | - | |||||||
Amortization of deferred finance costs | - | 156 | |||||||
Stock-based compensation and cost of licensee warrants | 184 | 568 | |||||||
Allowance for doubtful accounts | 20 | 173 | |||||||
Restructuring of certain contractual arrangements | 756 | - | |||||||
Proportional share of trademark amortization of equity method investee | 1,545 | 277 | |||||||
Loss on extinguishment of debt | - | 2,324 | |||||||
Deferred income tax benefit | - | 363 | |||||||
Net gain on sale of assets | - | (20,608 | ) | ||||||
Gain on sale of limited partner ownership interest | (351 | ) | - | ||||||
Gain on settlement of lease liability | (445 | ) | - | ||||||
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | (415 | ) | 747 | ||||||
Inventory | 1,848 | (509 | ) | ||||||
Prepaid expenses and other assets | 920 | 235 | |||||||
Deferred revenue | 4,676 | 199 | |||||||
Accounts payable, accrued expenses and other current liabilities | (1,395 | ) | (995 | ) | |||||
Lease-related assets and liabilities | (471 | ) | (202 | ) | |||||
Other Liabilities | - | (224 | ) | ||||||
Net cash used in by operating activities | (2,810 | ) | (11,029 | ) | |||||
Cash flows from investing activities | |||||||||
Net proceeds from sale of majority interest in Isaac Mizrahi brand | - | 45,408 | |||||||
Net proceeds from sale of assets | 451 | - | |||||||
Purchase of property and equipment | (87 | ) | (241 | ) | |||||
Net cash provided by investing activities | 364 | 45,167 | |||||||
Cash flows from financing activities | |||||||||
Proceeds from exercise of stock | 27 | ||||||||
Shares repurchased including vested restricted stock in exchange for withholding taxes | - | (442 | ) | ||||||
Payment of long-term debt | - | (29,000 | ) | ||||||
Payment of breakage fees associated with extinguishment of long-term debt | - | (1,511 | ) | ||||||
Net cash provided by (used in) financing activities | 27 | (30,953 | ) | ||||||
Net (decrease) increase in cash and cash equivalents | (2,419 | ) | 3,185 | ||||||
Cash and cash equivalents at beginning of period | 4,608 | 5,222 | |||||||
Cash and cash equivalents at end of period | $ | 2,189 | $ | 8,407 | |||||
Liability for equity-based bonuses and other equity-based payments | $ | - | $ | (283 | ) | ||||
Supplemental disclosure of cash flow information: | |||||||||
Cash paid during the period for interest | $ | - | $ | 1,032 | |||||
Cash paid during the period for income taxes | $ | 16 | $ | - | |||||
Non-GAAP net income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net income (loss) attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results. Adjusted EBITDA is the measure used to calculate compliance with the EBITDA covenant under our term loan agreement.
Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do. In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
($ in thousands) | Three Months Ended | Nine Months Ended | ||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
Net (loss) income attributable to |
$ | (5,144 | ) | (4,042 | ) | $ | (14,255 | ) | 1,961 | |||||||
Amortization of trademarks | 1,520 | 1,520 | 4,565 | 4,559 | ||||||||||||
Proportional share of trademark amortization of equity method investee | 515 | 742 | 1,545 | 742 | ||||||||||||
Stock-based compensation and cost of licensee warrants | 62 | 51 | 184 | 568 | ||||||||||||
Loss on extinguishment of debt | - | - | - | 2,324 | ||||||||||||
Gain on the sale of assets and investments | - | - | (351 | ) | (20,608 | ) | ||||||||||
Gain on lease termination | - | - | (445 | ) | - | |||||||||||
Asset impairment | - | - | 100 | - | ||||||||||||
Income tax benefit | - | (1,539 | ) | - | 1,639 | |||||||||||
Non-GAAP net loss | $ | (3,047 | ) | $ | (3,268 | ) | $ | (8,657 | ) | $ | (8,815 | ) | ||||
Three Months Ended | Nine Months Ended | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
Diluted (loss) earnings per share | $ | (0.26 | ) | $ | (0.21 | ) | $ | (0.72 | ) | $ | 0.10 | |||||
Amortization of trademarks | 0.08 | 0.08 | 0.23 | 0.23 | ||||||||||||
Proportional share of trademark amortization of equity method investee | 0.03 | 0.04 | 0.08 | 0.04 | ||||||||||||
Stock-based compensation and cost of licensee warrants | 0.00 | 0.00 | 0.01 | 0.03 | ||||||||||||
Loss on extinguishment of debt | - | - | - | 0.12 | ||||||||||||
Gain on the sale of assets and investments | - | - | (0.02 | ) | (1.05 | ) | ||||||||||
Gain on lease termination | - | - | (0.02 | ) | - | |||||||||||
Asset Impairment | - | - | 0.00 | - | ||||||||||||
Income tax benefit | - | (0.08 | ) | - | 0.08 | |||||||||||
Non-GAAP diluted EPS | $ | (0.15 | ) | $ | (0.17 | ) | $ | (0.44 | ) | $ | (0.45 | ) | ||||
Non-GAAP weighted average diluted shares | 19,749,317 | 19,624,860 | 19,683,525 | 19,624,604 | ||||||||||||
($ in thousands) | Three Months Ended | Nine Months Ended | ||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
Net loss attributable to |
$ | (5,144 | ) | $ | (4,042 | ) | $ | (14,255 | ) | $ | 1,961 | |||||
Depreciation and amortization | 1,677 | 1,815 | 5,260 | 5,447 | ||||||||||||
Proportional share of trademark amortization of equity method investee | 515 | 742 | 1,545 | 742 | ||||||||||||
Interest and finance expense | - | (6 | ) | 18 | 3,505 | |||||||||||
Income tax provision | - | (1,539 | ) | - | 1,639 | |||||||||||
State and local franchise taxes | 9 | 85 | 53 | 121 | ||||||||||||
Stock-based compensation and cost of licensee warrants | 62 | 51 | 184 | 568 | ||||||||||||
Gain on the sale of assets and investments | - | - | (351 | ) | (20,608 | ) | ||||||||||
Gain on lease termination | - | - | (445 | ) | - | |||||||||||
Asset impairment | - | - | 100 | - | ||||||||||||
Costs associated with restructuring of operations | 1,471 | - | 3,319 | - | ||||||||||||
Adjusted EBITDA | $ | (1,410 | ) | $ | (2,894 | ) | $ | (4,572 | ) | $ | (6,625 | ) | ||||
Source: Xcel Brands, Inc